Ursolic acid as a multifunctional anticancer agent with insights into molecular mechanisms therapeutic potential and formulation strategies
Open Access
- 10 April 2026
- journal article
- review article
- Published by Springer Nature in Discover Oncology
- Vol. 17 (1)
Abstract
The purpose of this review article is to comprehensively summarize the anticancer potential of Ursolic Acid (UA) by elucidating its underlying molecular mechanisms, therapeutic efficacy, and formulation advancements. It aims to highlight UA’s multifunctional role in modulating key cancer-related pathways and discuss recent progress in nano-formulation strategies designed to overcome its poor solubility and bioavailability, thereby facilitating its clinical translation. This review employs a comprehensive analysis of existing preclinical and limited clinical studies on UA, focusing on its molecular mechanisms and anticancer activities. It systematically examines literature related to key signalling pathways, therapeutic effects, and formulation advancements. Additionally, it evaluates nano-formulation approaches and combination therapies aimed at improving UA’s bioavailability and clinical applicability. The review reveals that UA demonstrates strong anticancer potential by inducing apoptosis, autophagy, and cell cycle arrest through modulation of key pathways like PI3K/Akt/mTOR, STAT3, and NF-κB. It suppresses metastasis, angiogenesis, and epithelial-mesenchymal transition, enhances antioxidant defence, and triggers ROS-mediated apoptosis. UA’s epigenetic modulation contributes to its anti-proliferative effects, while nano formulations improve its solubility, bioavailability, and targeted delivery, with early clinical studies showing good tolerance and preliminary signs of therapeutic benefit.UA emerges as a promising natural anticancer agent capable of targeting multiple molecular pathways involved in tumor growth and progression. Despite its broad preclinical efficacy, its poor solubility and low bioavailability limit clinical application. Advances in nano-formulation strategies have shown potential to overcome these challenges. However, extensive clinical investigations and standardized formulations are essential for successful therapeutic translation. Graphical AbstractKeywords
This publication has 63 references indexed in Scilit:
- Ursolic acid induces apoptosis in nasopharyngeal carcinoma cells through the P53 signaling pathway: a network pharmacology and experimental validation studyMedical Oncology, 2025
- Ursolic acid alleviates cancer cachexia by inhibiting STAT3 signaling pathways in C2C12 myotube and CT26 tumor-bearing mouse modelEuropean Journal of Pharmacology, 2024
- Ursolic acid regulates key EMT transcription factors, induces cell cycle arrest and apoptosis in MDA‐MB‐231 and MCF‐7 breast cancer cells, an in‐vitro and in silico studiesJournal of Cellular Biochemistry, 2023
- Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancerMolecular Carcinogenesis, 2021
- Synthesis and antileukemic activity of an ursolic acid derivative: A potential co-drug in combination with imatinibChemico-Biological Interactions, 2021
- Synthesis, anticancer evaluation and mechanism studies of novel indolequinone derivatives of ursolic acidBioorganic Chemistry, 2021
- Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine‐resistant human pancreatic cancer cellsPhytotherapy Research, 2020
- Ursolic acid induces apoptosis and autophagy in oral cancer cellsEnvironmental Toxicology, 2019
- A comparative study for the extraction methods and solvent selection for isolation, quantitative estimation and validation of ursolic acid in the leaves of Lantana camara by HPTLC methodFuture Journal of Pharmaceutical Sciences, 2018
- Development of a liquid chromatography–mass spectrometry method for the determination of ursolic acid in rat plasma and tissue: Application to the pharmacokinetic and tissue distribution studyAnalytical and Bioanalytical Chemistry, 2011